Carol Suh

227 posts

Carol Suh banner
Carol Suh

Carol Suh

@carolysuh

Company builder and Investor at ARCH Venture Partners. Biotech | Healthcare | Making medicines. My tweets are my own.

San Francisco, CA Katılım Ekim 2014
534 Takip Edilen1.4K Takipçiler
Carol Suh
Carol Suh@carolysuh·
Last night I had the honor of receiving @nvca’s Rising Star Award at their Leadership Awards Dinner. Such a cool event to be among investors across so many different industries, such as tech, AI, healthcare, energy, etc. all working to fund the next wave of innovation. Thank you to NVCA's Bobby Franklin for hosting such a great evening full of conversation around innovation, company building, and the future of the venture ecosystem. Grateful and energized. Ready for the next challenge.
Carol Suh tweet mediaCarol Suh tweet mediaCarol Suh tweet media
English
1
0
2
83
Carol Suh
Carol Suh@carolysuh·
It was great to film The Cure(ious) series with @NYSE at JPM this year and be part of a larger conversation on the future of innovation in our industry. The pace of progress in life sciences right now is remarkable, and it's exciting to see where the next wave of breakthroughs will come from.
BiotechTV@BiotechTV

𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩: In this @nyse video, industry leaders share some of the key principles they have in managing companies and leading teams in biotech and healthcare.

English
0
0
4
327
Carol Suh
Carol Suh@carolysuh·
Honored to be named a 2026 Rising Star Award recipient by @NVCA. This recognition means a great deal to me and is a reflection of the incredible teams and founders I’ve had the privilege to work alongside at ARCH Venture Partners and beyond. Proud to support visionary scientists and entrepreneurs by building and investing in transformative medicines and grateful to be part of a community advancing innovation for patients.
NVCA@nvca

Introducing the 2026 NVCA Rising Star Award winners! 🌟 Congratulations to: ⭐ @carolysuh, ARCH Venture Partners ⭐ Danaé Robert Johnson, @atoneventures ⭐ @jleites13 , @NorwestVP ⭐ Kathryn Taylor Reddy, @406Ventures ⭐ @webaficionado, @BatteryVentures Join us in celebrating these leaders and all of our 2026 Leadership Award honorees at the NVCA Leadership Awards Dinner on May 14 at Rosewood Sand Hill. 🔗 Register: cvent.me/02BGLz?utm_sou…

English
2
0
7
1.1K
Carol Suh
Carol Suh@carolysuh·
@john_evans3 That’s so awesome! Congrats to you and the Beam team!!
English
0
0
1
74
John Evans
John Evans@john_evans3·
On behalf of the Beam team, I’m honored to be included in the TIME100 2026 World’s Most Influential Leaders in Health for our work on base editing for the treatment of alpha-1 antitrypsin deficiency and for sickle cell disease: time.com/collections/ti…
English
4
0
18
2K
Carol Suh
Carol Suh@carolysuh·
Thrilled to see the next chapter for Orbital Therapeutics! As a co-founder and board member, it’s been a privilege to help build Orbital from inception. From Stanford @HowardYChang to making RNA medicines. Bringing this vision to life with ARCH Kristina Burow @gciaramella1 @john_evans3 and now seeing it recognized is deeply gratifying. Orbital advanced the boundaries of what’s possible in RNA therapeutics. I'm excited to see Bristol Myers Squibb taking this forward. Congratulations to the exceptional Orbital leadership and scientists, my fellow co-founders @JMaraganore , investors, and our partners who believed in the mission and vision from day one. businesswire.com/news/home/2025…
English
1
1
12
1.4K
Carol Suh retweetledi
Dr. Marty Makary
Dr. Marty Makary@DrMakaryFDA·
Today, I’m proud to introduce a revolutionary pathway to drug approvals that will significantly accelerate the delivery of crucial treatments to the American public. I'm committed to fostering innovation that saves lives. The National Priority Voucher program brings the agility of frontline medical decision-making to our regulatory processes.
U.S. FDA@US_FDA

Today, the FDA announced its Commissioner’s National Priority Voucher program to accelerate the delivery of crucial treatments to the American public. fda.gov/news-events/pr…

English
261
378
2K
329.1K
Carol Suh retweetledi
Allison DeAngelis
Allison DeAngelis@ADeAngelis_bio·
ARCH Venture Partners has raised $3 billion for a new fund — one of the largest in the biotech industry, and one the VC firm will use to continue its contrarian investment strategy. statnews.com/2024/09/26/arc…
English
0
2
7
773
Carol Suh
Carol Suh@carolysuh·
HiBio was incubated by ARCH & Monograph in the summer of 2021. It’s been a wild ride, but we’re most excited to see a potentially transformational medicine in the making. Proud & thankful to have been an investor & board member throughout the journey! investors.biogen.com/news-releases/…
English
0
1
32
3.9K
Carol Suh retweetledi
Neumora
Neumora@NeumoraTx·
Today we celebrate becoming a public company, trading on @Nasdaq under the symbol $NMRA. This marks an important step in our journey to confront the global brain disease crisis by redefining neuroscience drug development to make a difference for patients. #IPO
Neumora tweet mediaNeumora tweet mediaNeumora tweet media
English
2
10
49
16.2K
Carol Suh
Carol Suh@carolysuh·
Excited to announce Orbital’s Series A! Thank you to all our supporters and investors in helping us embark on this next wave of RNA medicines. - endpts.com/beams-rna-offs…
English
0
0
17
2.6K
Carol Suh
Carol Suh@carolysuh·
Thanks @natashaloder for highlighting the immense opportunity we have for developing better medicines for brain diseases @NeumoraTx #deconvolve #precisionneuroscience
Natasha Loder@natashaloder

🚨The latest @TheEconomist #TechnologyQuarterly is just out! It is about the brain, although specifically it tells the story of a renaissance in clinical neuroscience. 🧠 The illustrations are absolutely stunning. (timolenzen.com) Read it >> economist.com/technology-qua…

English
0
2
7
0
Carol Suh
Carol Suh@carolysuh·
Very excited to launch @OrbitalTx with @HowardYChang gene yeo @RaviMajetiMD drew Weissman @gciaramella1 @JMaraganore @KBurowARCH @john_evans3 @vintweeta Newpath partners. Thankful for everyone’s support in getting us here and now the real medicine making work begins 💪🏼
Robert Nelsen@rtnarch

Congrats to ARCH team that founded Orbital Therapeutics: Kristina Burow, Carol Suh, John Maraganore, Jay Parrish and Beam team, Pino Ciaramella, and co investors 16z, Vineeta Agarwala, and Newpath, Tom Cahill. World-leading science in multiple modalities of RNA in this one.

English
1
0
28
0

Keşfet

@nvca @NYSE @NVCA @john_evans3 @HowardYChang @gciaramella1 @JMaraganore @DrMakaryFDA